EU reshapes HTAs: is the industry ready for it?
Pharmaceutical Technology
FEBRUARY 14, 2025
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Pharmaceutical Technology
FEBRUARY 14, 2025
New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
Bio Pharma Dive
FEBRUARY 14, 2025
Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public in a challenging market for biotech stocks.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
FEBRUARY 14, 2025
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, the UK, and Japan - is projected to experience significant growth, with sales increasing from $2.3bn in 2023 to $5.2bn by 2033, according to leading data and analytics company GlobalData.
pharmaphorum
FEBRUARY 14, 2025
The EU has approved CSL's once-monthly Andembry for hereditary angioedema, challenging therapies from Takeda and Biocryst
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmaceutical Technology
FEBRUARY 14, 2025
Nemluvio, which was also approved for prurigo nodularis, becomes Galdermas first approved biologic in its dermatology arsenal.
pharmaphorum
FEBRUARY 14, 2025
Apple has started a major new health study to see how devices like the iPhone, Apple Watch, and AirPods can be used to monitor and improve our health.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
FEBRUARY 14, 2025
Discover how life science real estate clusters drive innovation and collaboration, leading to groundbreaking advancements in the industry. Explore the impact of these clusters and how they propel progress in life sciences.
Pharmaceutical Technology
FEBRUARY 14, 2025
Health Canada has approved Novartis Canadas Fabhalta (iptacopan capsules) as the first oral monotherapy to treat adults with PNH.
pharmaphorum
FEBRUARY 14, 2025
Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in an adjuvant melanoma study.
Pharmaceutical Commerce
FEBRUARY 14, 2025
The companys Mourenx plant in Southwest France aims to become an API network hub, with first supplies expected by next year.
pharmaphorum
FEBRUARY 14, 2025
Watch the video interview featuring Chris Moore, President Europe at Veeva, and Nicole Raleigh, Web Editor at pharmaphorum, as they discuss industry trends and insights.
Pharmaceutical Commerce
FEBRUARY 14, 2025
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Jenna Dale, director of client relations at Cencora, describes why these pharma supply chain stakeholders are vital in understanding meaningful clinical outcomes.
pharmaphorum
FEBRUARY 14, 2025
New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.
Pharmaceutical Commerce
FEBRUARY 14, 2025
The latest news for pharma industry insiders.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
FEBRUARY 14, 2025
Arcturus Therapeutics and CSL's COVID-19 vaccine Kostaive is the first in the new sa-mRNA class to be approved for marketing in the EU
Pharmaceutical Technology
FEBRUARY 14, 2025
CSL has received approval from the EC for Andembry (garadacimab) to prevent recurrent attacks of HAE in patients aged 12 years and above.
XTalks
FEBRUARY 14, 2025
Many people wonder how to gauge a companys influence in the healthcare sector. One way is to look at its market capitalization, which is the total value of its shares on the stock market. A larger market cap can signal stability, global reach and a strong capacity to address real-world challenges. In healthcare, these challenges often revolve around improving patient access, lowering costs and driving medical innovation.
Drug Patent Watch
FEBRUARY 14, 2025
The Hidden Risks of FDA-Approved Drugs: What You Need to Know As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug development and approval. But have you ever stopped to think about what happens after a drug receives FDA approval? While it's a major milestone, it's not the end of the road for many pharmaceuticals.
Drug Channels
FEBRUARY 14, 2025
Todays guest post comes from Angie Franks, CEO at Kalderos Angie describes the compliance challenges that stakeholders face in managing the complex interactions of the 340B Drug Pricing Program, the Medicaid Drug Rebate Program, and IRAs Maximum Fair Price and inflation rebate provisions. She explains how clean, comprehensive claims datacan resolve these issues.
Let's personalize your content